fbpx

New Look Vision Reports Results for Q2 of Fiscal 2020

New Look Vision Group reported financial results for the 13 and 26 week periods ended June 27, 2020 (“Q2 2020”) and provided updates on actions in response to COVID-19, store re-openings, and new financing arrangements.

Q2 2020 highlights, which were significantly impacted by COVID-19, are as follows:

• Revenues decreased by 64.9% to $27.4 million, resulting principally from COVID-19 temporary store closures, as well as scheduled store closures offset by revenue from newly acquired stores.

Cash flows related to operating activities reached $5.5 million, a decrease of $4.7 million or 46.3% from last year and decreased 47.0% on a per diluted share basis to $0.35.

• During the quarter, the Company successfully secured $73.9 million of additional bank and subordinated debt financing.

Year-to-date Financial and Operating Results

It should be noted that the Company has adopted IFRS 16 Leases effective Q1 2020. The Company has applied a modified retrospective approach: the operating results of previous fiscal periods have not been restated. Occupancy costs previously recorded as operating expenses are now recorded through depreciation of right-of-use assets and interest expenses on lease liabilities.

• The increase in the number of stores in the last twelve months reflects the acquisition of 19 stores net of five planned closures and the sale of one clinic.

• Net (loss)/earnings attributed to shareholders were ($12.7) million or ($0.81) per diluted share, compared to $8.9 million last year or $0.57 per diluted share.

• Adjusted net (loss)/earnings attributed to shareholders decreased to ($8.3) million, a decrease of $19.6 million, as compared to last year. Adjusted net (loss)/earnings attributed to shareholders reached ($0.53) per diluted share, down 173.6% from $0.72 in 2019.

• Cash flows related to operating activities reached $19.0 million, a decrease of 16.7% as compared to last year and decreased 17.1% on a per diluted share basis to $1.21.


Actions in response to COVID-19

New Look Vision has and continues to respond swiftly to the crisis along three principles: participation, protection and responsibility.

1. Participation in stemming the pandemic spread by closing a large number of locations early on (stores, offices, factories and distribution centers).

2. Protection for our employees with a supplemental pay program for those placed on temporary leave. Protection of our financial autonomy with immediate cash burn optimization (expense freeze, CAPEX postponement, dividend suspension, executive pay reduction) and expansion of our available funding from both our lenders. As a result, the Company is confident that it has the necessary financial resource to sustain the ongoing impact of the pandemic.

3. Responsibility, as eye care professionals, to keep open a minimum number of stores to serve those in urgent need of eye care and eyewear. The Company launched the Guardian Angel program on March 25th giving hospital personnel the opportunity to replace broken eyewear quickly. Our central lens processing facility retooled to produce safety eyewear for use in health care facilities.

Throughout the shutdown, teams working on strategic initiatives, both internal and external, have carried on. New Look Vision continues to diligently control its cost structure while actively monitoring market conditions.

Antoine Amiel, the President and CEO of New Look Vision, stated that: “The second quarter started after most of the Company’s retail stores stopped operating mid-March. Gradual reopening started mid-May and was completed by June 21st when the last local retail operation restrictions were lifted. In March, the Company implemented a high impact cash conservation plan which yielded minimum cash burn throughout the 90+ day physical retail shutdown. This, in addition to revenues generated online, is reflected in the strong cash position at quarter’s end, given the circumstances. Retail operations re-started in each market as soon as local regulatory restrictions allowed and under all-encompassing safety-first internal protocols. Trade has been brisk since the re-start. Strengthened by its resilience, financial and organizational strengths throughout the COVID-19 disruption, the Company has resumed its profitable growth journey, organic and external. I am, more than ever, in awe of the New Look Vision Group people’s fortitude through the ordeal and dedication to eyecare and eyewear since the re-start. They deserve the highest praise and deepest gratitude.”

Click HERE for the full press release.

Featured Posts

EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read More
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read More
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read More
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read More
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more